EcoDrugPlus

Fibroblast Growth Factor Receptor 2-Like

Ensembl ID : ENSOTSG00005017789
Gene Symbol: LOC112223890
3 Cross references
213 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSOTSG00005011660
Gene Symbol: FLT1
1 Cross references
192 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSOTSG00005011674
Gene Symbol: FLT3
1 Cross references
133 Possible Orthologues:

Folate Receptor

Ensembl ID : ENSOTSG00005001959
Gene Symbol: FOLR
1 Cross references
436 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSOTSG00005022021
Gene Symbol: FSHR
1 Cross references
200 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSOTSG00005005831
Gene Symbol: LOC112231356
2 Cross references
299 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSOTSG00005005829
Gene Symbol: LOC112231325
2 Cross references
331 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSOTSG00005032908
Gene Symbol: LOC112231356
2 Cross references
299 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSOTSG00005032910
Gene Symbol: LOC112231325
2 Cross references
331 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSOTSG00005031428
Gene Symbol: FRK
3 Cross references
156 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSOTSG00005017238
Gene Symbol: FRK
3 Cross references
156 Possible Orthologues:

Galactosidase, Alpha

Ensembl ID : ENSOTSG00005023317
Gene Symbol: GLA
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).